Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

University of Waterloo

$24,000.00

Aptamer-based biosensors for monitoring carbamazepine, a drug with a narrow therapeutic window

FY 2023-24

Summary
This application leverages the expertise of Dr. Juewen Liu at the University of Waterloo (Chemistry) to help a Canadian company, FluidAI develop a biosensor device that can be used for in vivo continuous monitoring of drugs with a narrow therapeutic window inside the body. The drug candidate to be monitored is carbamazepine for the treatment of epilepsy. The outcome will be field-deployable sensor devices that can reach the needed detection limits for this drug with the detection procedures compatible with the current workflow in hospitals. Aptamers are single-stranded oligonucleotides that can selectively bind to target molecules. DNA aptamers are chemically synthesized and thus can be mass produced with a good consistency. In addition, DNA aptamers can be designed into various types of biosensors for detecting a broad range of small molecular targets. In this project, we aim to develop aptamer-based biosensors for the detection of carbamazepine.
Program
Alliance Grants
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
586361-2023
Name nom
Liu, Juewen J
Department département
Chemistry
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
24000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Not available
Research subject en
Non disponible
Research subject fr
Non disponible
Application title
Aptamer-based biosensors for monitoring carbamazepine, a drug with a narrow therapeutic window
Keyword
aptamers; biosensors; DNA; drugs; SELEX
Application summary
This application leverages the expertise of Dr. Juewen Liu at the University of Waterloo (Chemistry) to help a Canadian company, FluidAI develop a biosensor device that can be used for in vivo continuous monitoring of drugs with a narrow therapeutic window inside the body. The drug candidate to be monitored is carbamazepine for the treatment of epilepsy. The outcome will be field-deployable sensor devices that can reach the needed detection limits for this drug with the detection procedures compatible with the current workflow in hospitals. Aptamers are single-stranded oligonucleotides that can selectively bind to target molecules. DNA aptamers are chemically synthesized and thus can be mass produced with a good consistency. In addition, DNA aptamers can be designed into various types of biosensors for detecting a broad range of small molecular targets. In this project, we aim to develop aptamer-based biosensors for the detection of carbamazepine.